NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA More...

Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Autolus Therapeutics (AUTL)

Technical Analysis Report for USA stock AUTL Autolus Therapeutics. Dated: 27 Jan 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics then click here. or read Experts views on Autolus Therapeutics or Forecast & share price targets of Autolus Therapeutics

Autolus Therapeutics Opened at 2.35 and Closed at: 2.26, which is -4.87% of previous session's close. It moved within a range of 2.25 and 2.43
The session was a Bearish session with an average volume of 885500, which is -72.73% of previous session's volumes.

• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 7 days back on short term averages

Support for tomorrow is 2.17 and resistance for tomorrow is 2.35
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.2, 2.13 resistance for tomorrow's hourly charts is 2.38, 2.49

10 Day SMA for Autolus Therapeutics (AUTL) is 2.25 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Autolus Therapeutics (AUTL) is 2.35 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Autolus Therapeutics (AUTL) is 2.63 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 3.31 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Autolus Therapeutics is 3.71 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Autolus Therapeutics is at 2.35 and 200 DMA is at 3.71, while 50 DMA and 100 DMA are at 2.63 and 3.31 respectively

Autolus Therapeutics (AUTL) moving average of 20 SMA is at 2.35 and 20 EMA is at 2.33

Autolus Therapeutics (AUTL) moving average of 50 SMA is at 2.63 and 50 EMA is at 2.67

Autolus Therapeutics (AUTL) moving average of 100 SMA is at 3.31 and 100 EMA is at 3.09

Autolus Therapeutics (AUTL) moving average of 200 SMA is at 3.71 and 200 EMA is at 3.55

Chemed Corp has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Chemed Corp, about 11.9% more returns!

Avanos Medical has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Avanos Medical, about 9.89% more returns!

Zymeworks Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Zymeworks Inc, about 2.12% more returns!

Sonoma Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Sonoma Pharmaceuticals, about 1.56% more returns!

Pacira Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 39.62% more returns!

Merit Medical has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 12.84% more returns!

Autolus Therapeutics has performed better than Leap Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!

Inmune Bio has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 72.8% more returns!

Grifols S has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 0.73% more returns!

Entera Bio has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Entera Bio, about 14.27% more returns!

Curis Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Curis Inc, about 7.01% more returns!

Autolus Therapeutics has performed better than Coherus Biosciences in short term. Holding Autolus Therapeutics could be a better choice for now!

Amarin Corporation has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 23.83% more returns!

Akari Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Akari Therapeutics, about 9.16% more returns!

Autolus Therapeutics Technical analysis of indicators

Price action analysis of Autolus Therapeutics (AUTL) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Autolus Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Autolus Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Autolus Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Autolus Therapeutics in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Autolus Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.25 and Autolus Therapeutics AUTL stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Autolus Therapeutics AUTL stock. Volume based technical analysis of Autolus Therapeutics AUTL stock is negative.

Autolus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AUTL Experts View which covers a lot of information including buying and selling signals

AUTL future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Autolus Therapeutics or View Candle Stick Charts here